AbbVie Inc. (ABBV)

AbbVie Revenue

In the year 2023, AbbVie had annual revenue of $54.32B, a decrease of -6.44%. Revenue in the quarter ending December 31, 2023 was $14.30B, a -5.42% decrease year-over-year.

• Revenue (ttm): $54.32B
• Revenue Growth: -6.44%
• P/S Ratio: 5.37
• Revenue / Employee: $1,086,360
• Employees: 50,000
• Market Cap: 291.56B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	54.32B	-3.74B	-6.44%
Dec 31, 2022	58.05B	1.86B	3.30%
Dec 31, 2021	56.20B	10.39B	22.69%
Dec 31, 2020	45.80B	12.54B	37.69%
Dec 31, 2019	33.27B	513.00M	1.57%
Dec 31, 2018	32.75B	4.54B	16.08%
Dec 31, 2017	28.22B	2.58B	10.06%
Dec 31, 2016	25.64B	2.78B	12.16%
Dec 31, 2015	22.86B	2.90B	14.52%
Dec 31, 2014	19.96B	1.17B	6.23%
Dec 31, 2013	18.79B	410.00M	2.23%
Dec 31, 2012	18.38B	936.00M	5.37%
Dec 31, 2011	17.44B	1.81B	11.55%
Dec 31, 2010	15.64B	1.42B	10.02%
Dec 31, 2009	14.21B	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.